Metformin Cost in Montana 2026: Cash Price, Medicaid, Insurance, and Compounded Options

What Does Metformin Actually Cost in Montana in 2026?

Generic metformin is one of the most affordable prescription drugs available anywhere in the United States, and Montana is no exception. At retail pharmacies across the state, including chains like Walmart, Walgreens, Smith's, and independent rural pharmacies, the average cash price for a 30-day supply of metformin 500 mg twice daily runs about $8 per month in 2026. With a GoodRx coupon or the Cost Plus Drugs platform, that price can drop below $4 for the same supply.

The manufacturer's suggested list price for branded or authorized generic versions sits around $40 per month, but almost no cash-pay patient pays that figure. The generic market for metformin is saturated, which keeps retail prices low. According to GoodRx data, 500 mg metformin (60 tablets, a one-month supply at the standard starting dose) costs between $4 and $14 at most Montana ZIP codes in 2026, depending on pharmacy.

The FDA approved metformin hydrochloride oral tablets for type 2 diabetes in adults in 1994. The current FDA label is available through the FDA's drug database. The drug's safety record now spans three decades of post-market surveillance. A landmark study, UKPDS 34 (N=1,704 overweight patients with newly diagnosed type 2 diabetes), found that metformin reduced all-cause mortality by 36% and diabetes-related deaths by 42% compared to conventional diet therapy over a median 10.7 years of follow-up. [1]

Beyond retail, two other pricing tiers matter in Montana. First, federally qualified health centers (FQHCs) in the state, including those in Great Falls, Billings, and Missoula, dispense metformin at 340B pricing, which can bring cost to near zero for qualifying low-income patients. The Health Resources and Services Administration maintains a public 340B covered entity database. Second, compounded metformin from a licensed 503A compounding pharmacy is another route, discussed in detail below.

The American Diabetes Association's 2024 Standards of Care name metformin as a first-line pharmacologic agent for type 2 diabetes management, citing its long efficacy record, safety profile, and low cost. [2] That guideline status means virtually every formulary in the country, including Montana's Medicaid preferred drug list, includes it.

Does Montana Medicaid Cover Metformin?

Montana Medicaid covers metformin for members diagnosed with type 2 diabetes, and the drug sits on the state's preferred drug list without a prior authorization requirement for standard immediate-release tablets. Montana's Medicaid program, administered by the Department of Public Health and Human Services (DPHHS), follows a fee-for-service model with several managed care carve-outs in specific regions. In all cases, metformin IR appears on Tier 1 (preferred generics), meaning the copay for most members is $0 to $3 per fill.

Montana expanded Medicaid under the Affordable Care Act in 2016. As of January 2025, roughly 280,000 Montanans were enrolled in Medicaid or CHIP, representing about 26% of the state population. The Kaiser Family Foundation tracks state-level Medicaid enrollment. Adults with household income at or below 138% of the federal poverty level ($20,783 for a single adult in 2025) qualify for full Medicaid benefits, which include prescription drug coverage.

Extended-release metformin (metformin ER, brand Glumetza) requires a prior authorization in Montana Medicaid because lower-cost IR tablets are available. A prescriber can request PA if a patient has documented GI intolerance to the IR formulation. The Montana DPHHS pharmacy program publishes its preferred drug list here.

One commonly missed point: Montana Medicaid also covers metformin for members with prediabetes in some circumstances when prescribed as part of a Diabetes Prevention Program (DPP) enrollment. Prescribers should document HbA1c between 5.7% and 6.4% and a failed lifestyle intervention attempt to support coverage. The CDC's National DPP framework outlines eligibility criteria used by state programs to justify metformin prescribing in prediabetes. [3]

For members who lose Medicaid eligibility or who are in a coverage gap, the transition to commercial pricing is manageable given metformin's low cash cost, but a social worker referral to Montana's DPHHS HELP-Link program can assist with re-enrollment.

Which Commercial Insurance Plans Cover Metformin in Montana?

Every major commercial insurer operating in Montana covers generic metformin, typically at Tier 1 with a $0, $10 copay per 30-day fill. Carriers active in Montana's individual and employer markets include Blue Cross Blue Shield of Montana, PacificSource, Montana Health CO-OP, and Cigna. All four list metformin IR on their lowest formulary tier.

The Affordable Care Act requires non-grandfathered plans to cover preventive services at no cost-sharing when a USPSTF grade A or B recommendation applies. The USPSTF issued a grade B recommendation in 2021 for metformin use to prevent progression from prediabetes to type 2 diabetes in adults who are 35 to 70 years old and have a BMI of 25 or higher. [4] Under that rule, qualifying patients may receive metformin for prediabetes with zero cost-sharing from their commercial insurer, even if it would otherwise carry a copay as a Tier 1 drug.

Patients should confirm this zero-cost-sharing benefit directly with their plan. The exact billing pathway varies: some plans process it under a preventive services benefit code, others under a standard pharmacy benefit. A prescriber's note documenting the prediabetes indication and USPSTF criteria on the prescription can prevent a claim denial. The USPSTF recommendation statement is available at the USPSTF website.

Medicare Part D plans available in Montana (there were 22 standalone PDP options in 2025) universally place metformin IR on Tier 1. The average Tier 1 copay for Part D plans in Montana is $0 during the initial coverage phase. The Medicare Plan Finder tracks formulary tiers by county.

Is Compounded Metformin Legal in Montana?

Compounded metformin is legal in Montana when prepared by a state-licensed 503A pharmacy operating under a valid prescription for an individual patient. Montana's Board of Pharmacy regulates 503A compounding pharmacies under state statute and the federal Drug Quality and Security Act of 2013. A 503A pharmacy may compound metformin in non-commercially available forms (for example, a lower-dose capsule for a pediatric patient, or a liquid formulation for someone who cannot swallow tablets) as long as it is not compounding a copy of an FDA-approved product without a specific patient need.

The legal nuance matters. Because metformin tablets are FDA-approved and commercially available, a 503A pharmacy in Montana cannot compound standard 500 mg or 1 to 000 mg tablets simply to undercut retail pricing. The pharmacy must have a documented clinical rationale, such as a unique dose, a different delivery form, or a documented allergy to an excipient in the commercial tablet. The FDA's guidance on 503A pharmacy compounding covers this distinction in detail.

Some telehealth companies advertise "compounded metformin" at $0 per month as part of bundled programs. In those programs, the compounded product typically serves a specific clinical purpose documented in the patient chart, such as a custom dose for a GLP-1 combination protocol. Montana prescribers and patients should verify that the compounding pharmacy holds a current Montana Board of Pharmacy license and that the prescription includes a documented clinical rationale. The Montana Board of Pharmacy license verification tool is available online.

A 2023 analysis published in JAMA Internal Medicine found that the out-of-pocket cost of prescription medications was the primary barrier to adherence for 22% of adults with type 2 diabetes surveyed across nine states. [5] Compounded formulations at lower cost may improve adherence in specific patients, but clinical rationale must drive the decision, not cost alone.

Can I Get a Metformin Prescription via Telehealth in Montana?

Telehealth prescribing of metformin is fully legal in Montana. Montana law (MCA 37-3-102) permits physicians, nurse practitioners, and physician assistants to prescribe medications via synchronous audio-visual telehealth after conducting an appropriate clinical evaluation. Metformin is not a controlled substance, so no in-person visit requirement applies under either state or federal law.

A telehealth visit for metformin typically involves a review of a recent HbA1c result (drawn at a local lab or via a mail-in test kit), fasting glucose, a basic metabolic panel to check renal function, and a brief cardiovascular and GI history. The FDA label for metformin contraindications includes an estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m2, at which point the drug should not be initiated. [6] For eGFR between 30 and 45, the label recommends reassessing benefit versus risk and dose adjustment.

Montana has a high proportion of rural residents, with 44% of the population living in counties classified as rural by the USDA. The USDA Economic Research Service publishes rural-urban continuum codes by state. For those patients, telehealth removes a significant barrier. A patient in Jordan, MT (population roughly 340) can complete a metformin evaluation, get labs drawn at the nearest critical access hospital, and have a prescription sent electronically to their local pharmacy, all without a 200-mile round trip to a specialist.

HealthRX and similar telehealth platforms operating in Montana can prescribe metformin within a single visit when labs are already available. Standard turnaround from initial intake to pharmacy transmission is 24 to 48 hours.

What Are the Cheapest Ways to Get Metformin in Montana?

The lowest cost options for Montana patients, ranked from least to most expensive, break down as follows.

Cost Plus Drugs (Mark Cuban's pharmacy). Metformin 500 mg, 60 tablets (one month at the standard twice-daily starting dose) costs $1.80 plus a $5 shipping fee on the Cost Plus Drugs platform. For a 90-day supply, that is $5.40 in drug cost plus shipping. Cost Plus Drugs publishes its pricing publicly. This is the single cheapest verified option for uninsured Montana patients as of 2026.

GoodRx coupons at local pharmacies. GoodRx consistently brings the retail cash price at Walmart, Walgreens, and Smith's pharmacies in Billings, Missoula, Great Falls, and Bozeman to $4, $9 per 30-day supply for 500 mg tablets. GoodRx is free to use and does not require enrollment. GoodRx publishes coupon prices by ZIP code.

Walmart $4 generic program. Walmart's in-store pharmacy lists metformin IR in its $4 per month / $10 per 90-day generic program at Montana store locations. No coupon or membership is required at point of sale.

Montana Medicaid (for eligible patients). Tier 1 copay is $0, $3 per fill with no prior authorization for metformin IR. This is effectively free for members who qualify.

340B health centers. FQHCs and rural health clinics with 340B status in Montana dispense metformin at near-zero cost to eligible low-income patients. Income-qualifying patients should ask their provider whether their clinic participates in 340B.

Manufacturer patient assistance. Because metformin is generic, brand-manufacturer programs (like those from AstraZeneca for Glucophage) are not relevant for most patients. Generic manufacturer PAPs exist but are rarely needed given the low cash price.

A systematic review published in the Annals of Internal Medicine (Nuckols et al., 2014, N=31 studies) found that medication cost-reduction interventions lowered patient out-of-pocket costs by a mean of $187 per year and improved medication adherence by a statistically significant margin. [7] For a drug as affordable as generic metformin, the marginal gain from program enrollment is small in dollar terms but adherence effects are real.

How Metformin Works and Why Dose Matters for Cost

Understanding how metformin works clarifies why the dose you are prescribed directly affects your monthly cost. Metformin reduces hepatic glucose production by activating AMP-activated protein kinase (AMPK), increases peripheral glucose uptake, and mildly reduces intestinal glucose absorption. [8] It does not stimulate insulin secretion and therefore carries negligible hypoglycemia risk as monotherapy.

Standard dosing starts at 500 mg once or twice daily with meals, titrated over 4 to 8 weeks to a target of 1,000 to 2 to 000 mg per day in divided doses. The ADA Standards of Care 2024 outline this titration schedule. Higher doses cost more but the increment is modest: 90 tablets of 1 to 000 mg at Cost Plus Drugs costs roughly $3.60, compared to $1.80 for 60 tablets of 500 mg.

Extended-release metformin (metformin ER) is taken once daily with the evening meal. It has a lower rate of GI side effects (nausea, diarrhea) and costs slightly more than IR at cash-pay pharmacies, typically $10, $18 per month at Montana retail compared to $4, $9 for IR. If a patient tolerates IR, switching to ER for cost reasons alone is not necessary.

The UKPDS 34 trial, the foundational evidence for metformin, used a median dose of 2 to 550 mg per day. [1] That dose produced a 0.6% absolute HbA1c reduction compared to conventional therapy (diet alone) and the 36% all-cause mortality reduction cited above. Most patients in clinical practice achieve adequate glycemic control at 1,500 to 2 to 000 mg per day.

Metformin for Weight Loss and Longevity: Does Cost Change?

Metformin is prescribed off-label for weight management, polycystic ovary syndrome (PCOS), and aging-related metabolic conditions. Insurance coverage for these off-label uses varies, and Montana Medicaid generally covers metformin only for the approved type 2 diabetes indication.

For off-label use (PCOS, weight loss, longevity protocols), Montana patients typically pay cash. At $4, $9 per month via GoodRx, this is affordable for most patients, but telehealth programs that bundle metformin with a GLP-1 agonist or other peptide therapy should be transparent about which cost covers which drug. A bundled "program fee" that includes compounded metformin should be scrutinized, as described in the compounding section above.

The DIABETES PREVENTION PROGRAM (DPP) trial (N=3,234) showed that metformin 850 mg twice daily reduced the incidence of type 2 diabetes by 31% compared to placebo over 2.8 years in adults with prediabetes and elevated fasting glucose. [9] That trial was funded by the NIH and remains the most cited evidence for metformin in prediabetes. For PCOS, a Cochrane review (Tang et al., 2012) of 44 randomized trials found that metformin improved menstrual regularity and reduced androgen levels compared to placebo. [10]

The HealthRX Montana Metformin Cost Decision Framework distills the options above into three patient profiles. Profile 1: insured Montana resident with type 2 diabetes. Use your insurance Tier 1 benefit; confirm $0 cost-sharing if the USPSTF prediabetes indication applies. Profile 2: uninsured Montana resident or coverage gap. Use Cost Plus Drugs ($1.80/month for 500 mg) or GoodRx at Walmart ($4/month). Profile 3: Medicaid-eligible Montana resident. Confirm enrollment with DPHHS HELP-Link and fill at any participating pharmacy for $0, $3 per fill.

Renal Safety Monitoring: A Cost That Cannot Be Skipped

Metformin's most serious risk is lactic acidosis in patients with severely impaired renal function. The incidence is rare, estimated at 3 to 10 cases per 100,000 patient-years in clinical literature, but the mortality rate when it occurs is approximately 50%. The FDA metformin label details the contraindications and monitoring requirements. [6]

Current FDA guidance, updated in 2016, permits metformin use in patients with eGFR as low as 30 mL/min/1.73 m2 with dose adjustment. Patients should have eGFR checked before starting metformin and at least annually thereafter. In Montana, a basic metabolic panel (BMP) costs $15, $40 at a retail clinic or quest diagnostics draw site without insurance, a cost worth framing alongside the $8/month drug cost when counseling patients on total therapy expense.

Hold metformin 48 hours before and after iodinated contrast procedures (CT scans with contrast dye) if eGFR is <60, per the American College of Radiology guidance. The ACR manual on contrast media is available at acr.org.

Vitamin B12 deficiency is a known long-term effect of metformin. A cross-sectional analysis in the Annals of Internal Medicine (Aroda et al., 2016, from the DPP Outcomes Study, N=857) found that 4.3% of participants on metformin had vitamin B12 deficiency (defined as <203 pg/mL) compared to 2.3% on placebo. [11] Annual B12 screening adds roughly $25, $50 to yearly monitoring costs. Supplementation with 500, 1 to 000 mcg of oral B12 daily is inexpensive and adequate for most patients with metformin-related depletion.

Starting Metformin in Montana: The Clinical Pathway

A standard first prescription in Montana proceeds as follows. A prescriber, either in-person or via telehealth, orders a BMP (to confirm eGFR and baseline glucose) and an HbA1c. Results available within 24 to 72 hours from a local Quest, LabCorp, or hospital outpatient lab. The prescriber reviews results, confirms no contraindications, and e-prescribes metformin IR 500 mg twice daily with food to the patient's preferred pharmacy.

The pharmacy fills the prescription. The patient presents their insurance card or GoodRx coupon. Total out-of-pocket for the first month: $0 to $9 depending on coverage tier. The prescriber schedules a 4-week follow-up, by phone or video if telehealth, to assess GI tolerability and titrate the dose toward the target of 1,500 to 2 to 000 mg daily over 4 to 8 weeks. The ADA 2024 Standards of Care Section 9 outlines this titration. [2]

HbA1c is rechecked at 3 months. A response is defined as a reduction of at least 0.5 percentage points. If HbA1c remains above target (typically 7.0% for most adults, per ADA guideline), add-on therapy is considered. The GRADE trial (N=5,047), published in the New England Journal of Medicine in 2022, compared four second-line agents added to metformin monotherapy and found that a GLP-1 agonist (liraglutide) produced the greatest HbA1c reduction and the lowest rate of hypoglycemia over 5 years. [12]

For Montana patients starting metformin through HealthRX's telehealth program, the first lab order is sent electronically on the day of the intake visit. Most rural Montana patients can access a Quest Diagnostics patient service center in Billings, Great Falls, Missoula, Helena, or Bozeman, or use a mail-in test kit if within 90 miles of the nearest draw site. The prescriber reviews results and completes the prescription within one business day of receiving them.

Montana's average monthly cost for metformin in 2026 is $8 at retail cash price, making it one of the least expensive chronic disease medications available anywhere in the state.